This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
180 |
4. Check minimum number of eventsNone |
180 |
5. Include endpointsNone |
180 |
6. Filter based on genotype QC (FinnGen only) |
180 |
Control definitions (FinnGen only)
- Control exclude
- R18_GENERAL_SYMPTOMS_SIGNS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R[5-6]
- Name in latin
- Cachexia
Similar endpoints
↥List of similar endpoints to
Cachexia
based on the number of shared cases.
Similar with more cases:
- General symptoms and signs
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 180 | 74 | 106 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.05 |
| Median age at first event (years) | 72.18 | 67.87 | 75.20 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 158
- Matched controls
- 1578
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R64
ICD-10 Finland
Cachexia
+∞
228.4
158
*
R63.4
ICD-10 Finland
Abnormal weight loss
42.2
18.1
22
6
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.4
15.1
69
238
R53
ICD-10 Finland
Malaise and fatigue
5.8
14.4
44
98
D64.9
ICD-10 Finland
Anaemia, unspecified
5.0
11.0
37
90
R50.9
ICD-10 Finland
Fever, unspecified
7.9
10.6
24
35
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
4.1
10.1
43
132
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.2
10.0
65
281
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.1
9.2
38
113
B03BA03
ATC
hydroxocobalamin; parenteral
6.0
9.1
25
48
R55
ICD-10 Finland
Syncope and collapse
11.7
9.0
16
15
Z51.5
ICD-10 Finland
Palliative care
5.3
8.8
27
59
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.0
8.6
65
302
E86
ICD-10 Finland
Volume depletion
16.1
7.8
12
8
R18
ICD-10 Finland
Ascites
19.5
7.7
11
6
N02AA05
ATC
oxycodone; systemic
3.6
7.7
36
119
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
6.2
7.7
20
36
R03BB04
ATC
tiotropium bromide; inhalant
3.9
7.6
32
97
R63.0
ICD-10 Finland
Anorexia
+∞
7.3
7
*
R13
ICD-10 Finland
Dysphagia
5.8
7.0
19
36
A28
ICPC
Limited function/disability NOS
3.2
6.9
39
148
A04AA01
ATC
ondansetron; systemic, rectal
6.7
6.7
16
26
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.2
6.5
36
134
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
72.6
6.5
7
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
9.2
6.2
12
14
JN4BD
NOMESCO Finland
Extensive body CT
4.0
6.0
23
64
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
83
303
4.23
20.08
2.6
1.9
mg/l
2.9
3.1
0.37
72
258
(3003458) Phosphate [Moles/volume] in Serum or Plasma
54
149
4.75
18.77
6.0
5.9
mmol/l
1.0
1.0
0.01
48
137
(3023368) Bacteria identified in Blood by Culture
82
338
3.62
15.92
6.2
3.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
105
513
3.51
15.45
8.2
4.3
g/l
31.0
35.2
7.13
98
468
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
28
8.36
15.17
1.6
1.2
ug/g
281.3
321.3
0.28
15
13
(40760888) Immunoglobulin light chains.free panel - Serum
18
22
8.98
13.88
2.6
2.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
32
74
5.04
13.50
2.2
1.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
104
550
3.11
12.61
10.8
4.7
mmol/l
1.2
1.2
0.90
96
479
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
41
123
4.02
12.41
2.4
2.4
umol/l
6.2
10.3
0.95
35
105
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
109
600
3.07
12.16
10.0
5.5
mmol/l
1.2
1.2
1.31
82
500
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
20
33
6.69
11.94
2.9
2.2
mg/l
30.9
37.1
0.42
13
28
(3034860) Kappa light chains.free [Mass/volume] in Serum
20
33
6.69
11.94
3.0
2.2
mg/l
48.9
242.0
0.54
14
28
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
22
41
5.97
11.67
2.0
1.6
ug/l
1.8
0.6
0.94
22
33
(3021960) Folate [Moles/volume] in Serum or Plasma
69
305
3.05
11.25
1.8
1.5
nmol/l
20.0
20.2
0.05
63
247
(3001122) Ferritin [Mass/volume] in Serum or Plasma
95
500
2.91
11.25
3.4
2.5
ug/l
236.8
138.1
2.40
87
447
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
25
7.40
11.22
2.0
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
77
367
2.92
10.90
6.1
4.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
19
35
5.95
10.16
4.3
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
16
26
6.66
9.63
5.6
4.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
34
106
3.72
9.62
2.4
2.9
e9/l
63.7
65.5
0.13
27
84
(3032080) INR in Blood by Coagulation assay
91
505
2.62
9.22
8.0
8.2
inr
1.2
1.3
0.80
27
136
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
46
183
3.03
8.79
2.4
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
28
81
3.91
8.78
2.2
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
73
373
2.61
8.65
7.8
3.6
ph
7.4
7.4
0.14
21
65
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
12
16
7.96
8.51
3.1
3.4
%
57.3
57.9
0.04
12
16
(3019309) Folate [Moles/volume] in Red Blood Cells
57
260
2.74
8.44
2.6
1.8
nmol/l
1292.2
1232.8
0.16
42
193
(3042936) Bacteria identified in Isolate by Culture
44
179
2.93
8.03
2.4
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
67
3.98
7.88
1.8
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
65
330
2.52
7.65
2.8
1.9
u/l
125.2
371.7
1.95
59
306
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
15
7.75
7.64
3.4
3.5
e9/l
4.9
4.1
0.52
11
15
(3003396) Base excess in Arterial blood by calculation
36
138
3.01
7.26
8.4
5.8
mmol/l
1.3
1.1
0.06
24
114
(40768797) Stomach Pathology biopsy report
38
151
2.92
7.19
1.5
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
85
500
2.33
7.09
6.0
3.6
ng/l
64.9
49.4
0.44
72
377
(3026008) Bacteria identified in Urine by Culture
70
380
2.38
7.02
4.4
2.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
91
554
2.30
6.97
7.8
4.8
e9/l
0.7
0.6
1.26
85
477
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
17
6.83
6.86
1.6
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
15
32
5.02
6.82
1.3
1.1
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
91
558
2.28
6.81
7.8
4.9
e9/l
0.0
0.0
0.11
86
484
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
26
86
3.36
6.66
1.9
1.7
%
1.9
1.6
0.66
21
77
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
29
5.15
6.57
1.8
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
37
152
2.81
6.56
1.6
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
85
514
2.24
6.50
2.5
2.0
pmol/l
82.3
92.7
1.20
50
267
(3013650) Neutrophils [#/volume] in Blood by Automated count
102
666
2.23
6.43
13.5
7.0
e9/l
4.9
4.3
1.22
95
573
(3019198) Lymphocytes [#/volume] in Blood
91
570
2.21
6.33
7.9
4.9
e9/l
1.6
1.8
1.50
86
505
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
19
6.10
6.18
1.6
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
92
584
2.18
6.14
8.1
5.2
e9/l
0.2
0.2
0.53
86
514
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
79
474
2.19
6.06
3.3
2.3
nmol/l
79.0
78.2
0.07
70
407
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
25
86
3.21
6.01
5.7
3.6
kpa
5.4
5.2
0.65
25
72
(3037121) Protein [Mass/volume] in Urine
15
36
4.45
5.95
4.1
3.1
g/l
0.8
0.2
—
7
11
(3002032) Base excess in Venous blood by calculation
28
105
2.97
5.83
5.5
4.0
mmol/l
4.6
1.4
1.82
20
85
(3002582) Erythrocytes [#/volume] in Urine
66
375
2.20
5.74
3.6
3.2
e6/l
19.5
242.4
0.72
55
292
(3026782) Osmolality of Urine
50
253
2.35
5.73
3.4
2.5
mosm/kgh2o
505.6
558.4
1.31
44
212
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
74
441
2.15
5.70
3.8
3.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
115
815
2.14
5.57
6.3
4.1
e6/l
14.6
3007.0
—
5
24
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
43
3.99
5.50
2.2
1.5
g/l
4.0
3.8
—
8
30
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
43
3.99
5.50
2.2
1.5
g/l
7.3
7.6
—
8
32
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
43
3.99
5.50
2.2
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
40
186
2.48
5.50
1.5
1.3
g/l
3.1
2.4
1.74
30
103
(3012544) pH of Venous blood
28
109
2.86
5.45
5.5
4.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
30
122
2.75
5.38
2.7
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
58
323
2.17
5.24
3.2
3.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
11
23
5.03
5.08
1.8
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
98
670
2.02
5.05
4.8
2.7
u/l
67.1
45.0
1.19
91
621
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
41
3.90
5.04
2.3
1.5
g/l
3.1
3.3
—
8
31
(3018677) aPTT in Platelet poor plasma by Coagulation assay
40
194
2.37
4.99
2.5
1.7
s
29.7
29.3
0.26
40
186
(40760892) CBC W Ordered Manual Differential panel - Blood
44
227
2.24
4.75
7.7
4.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
29
124
2.60
4.71
2.7
1.6
—
—
—
0
0
(3010421) pH of Blood
13
34
4.04
4.62
7.6
3.5
ph
7.4
7.4
0.12
13
28
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
39
3.81
4.58
1.4
1.6
g/l
9.3
11.1
—
9
33
(3030467) Casts [#/volume] in Urine by Automated count
58
339
2.05
4.54
3.2
3.1
e6/l
1.2
0.5
0.68
50
253
(3019060) Gas panel - Arterial blood
22
83
2.88
4.52
10.8
3.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
26
4.44
4.42
4.6
2.9
—
—
—
0
0
(4281824)
9
12
7.83
4.41
1.3
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
67
417
1.97
4.37
3.1
3.0
ng/l
5634.5
1944.2
1.30
57
352
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
9
9.23
4.32
1.9
1.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
70
444
1.94
4.31
4.8
3.5
e6/l
75.3
79.1
0.04
58
316
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
13
7.22
4.21
1.4
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
18
63
3.06
4.20
6.2
3.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
31
146
2.36
4.10
3.6
4.3
ug/l
1034.7
10.6
0.50
26
122
(3042631) Mycobacterium sp identified in Specimen
8
10
8.31
4.10
5.0
1.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
113
851
1.88
4.00
5.4
3.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
23
100
2.49
3.61
4.7
3.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
34
176
2.15
3.60
17.2
26.8
inr
1.9
1.5
—
5
22
(3000093) Morphology [Interpretation] in Blood Narrative
7
9
8.03
3.59
1.0
1.6
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
9
17
5.51
3.56
1.6
1.3
mmol/l
6.4
6.9
—
9
17
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
13
6.38
3.54
1.3
1.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
14
47
3.15
3.50
1.4
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
59
376
1.85
3.46
3.9
2.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
27
3.86
3.40
1.6
1.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
21
91
2.48
3.32
2.5
3.4
%
0.4
0.9
—
10
30
(3015377) Calcium [Moles/volume] in Serum or Plasma
62
407
1.80
3.28
3.9
3.0
mmol/l
2.3
2.4
0.94
52
354
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
37
206
2.00
3.22
1.5
1.2
u/ml
1.0
0.9
0.12
11
47
(3035880) pH of Pleural fluid
7
11
6.57
3.21
1.3
1.1
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
16
5.18
3.08
1.9
1.9
pg
33.5
32.8
—
8
16
(44790047)
6
8
7.71
3.08
1.2
1.1
—
—
—
0
0
(44790048)
6
8
7.71
3.08
1.2
1.1
—
—
—
0
0
(44790049)
6
8
7.71
3.08
1.2
1.1
—
—
—
0
0
(44806118)
6
8
7.71
3.08
1.2
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
8
7.71
3.08
1.8
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
8
7.71
3.08
1.7
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
51
2.89
3.06
1.5
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
39
226
1.93
3.03
4.7
3.1
ng/l
625.8
266.5
0.42
32
193
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
5
10.23
2.99
1.6
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
5
10.23
2.99
1.6
1.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
8
17
4.87
2.95
1.9
1.3
u/l
100.4
287.7
—
8
17
(3037522) Nuclear Ab [Titer] in Serum
22
103
2.29
2.95
1.4
1.4
titre
506.7
400.0
—
6
23
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
27
139
2.11
2.89
5.3
3.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
9
6.85
2.89
1.2
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
77
555
1.68
2.85
7.1
4.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
78
2.45
2.85
2.2
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
19
86
2.35
2.75
2.3
3.5
%
0.0
0.1
—
9
27
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
10
6.16
2.72
1.7
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
21
100
2.25
2.71
7.7
7.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
18
80
2.39
2.71
2.2
3.7
%
0.0
0.4
—
9
22
(3013707) Erythrocyte sedimentation rate by Westergren method
110
883
1.63
2.58
5.5
3.6
mm/h
21.5
13.0
4.61
103
803
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
7
7.30
2.56
1.6
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
7
7.30
2.56
1.6
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
7
7.30
2.56
1.6
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
11
5.60
2.56
1.5
3.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
16
323
0.45
2.53
1.7
1.5
mmol/l
1.0
1.3
1.49
11
258
(3037756) Immunofixation for Serum or Plasma
9
26
3.59
2.52
1.9
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
7
16
4.51
2.50
1.4
1.4
u/l
27.4
11.0
—
7
16
(3015235) Bicarbonate [Moles/volume] in Capillary blood
11
40
2.86
2.42
6.1
2.9
mmol/l
26.4
25.3
0.27
11
29
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
22
3.75
2.39
1.8
1.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
5
8
6.39
2.38
1.4
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
5
8
6.39
2.38
1.4
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
8
6.39
2.38
1.0
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
5
8
6.39
2.38
1.4
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
8
6.39
2.38
1.4
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
7
17
4.24
2.38
4.3
1.3
mmol/l
1.7
1.9
—
7
17
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
47
2.66
2.32
1.2
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
13
4.73
2.29
1.7
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
13
4.73
2.29
3.8
1.2
%
86.5
90.5
—
6
13
(3044927) Protein electrophoresis panel - Urine
6
13
4.73
2.29
1.3
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
44
288
1.70
2.27
3.3
2.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
70
516
1.58
2.26
24.0
8.2
e9/l
0.0
0.0
0.49
61
429
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
9
5.68
2.23
1.4
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
9
5.68
2.23
1.4
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
5
9
5.68
2.23
2.4
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
19
3.79
2.17
1.0
2.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
19
3.79
2.17
3.7
4.3
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
6
14
4.39
2.17
1.8
1.7
u/l
9.7
12.2
—
6
14
(3019225) pH of Specimen
22
118
1.98
2.13
3.9
3.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
32
195
1.78
2.11
2.8
2.9
e6/l
1.9
1.3
0.38
22
106
(3028308) Erythrocytes [#/volume] in Pleural fluid
7
21
3.42
1.98
2.0
1.2
e6/l
5129.6
35847.2
—
7
16
(3052851) Hemolysis interference index of Serum or Plasma
10
39
2.66
1.95
5.2
3.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
104
1214
0.66
1.95
4.0
5.2
mmol/l
2.2
2.6
5.03
94
1098
(3045788) Cell count panel - Pleural fluid
6
16
3.84
1.95
2.2
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
41
275
1.64
1.92
2.3
1.9
pmol/l
482.8
25676108.4
0.50
35
222
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
106
879
1.50
1.90
3.9
3.5
pmol/l
14.9
15.0
0.15
94
762
(3023199) Leukocytes [#/volume] in Pleural fluid
7
22
3.27
1.90
2.0
1.3
e6/l
11892.4
1781.4
—
7
17
(3012441) Differential panel - Pleural fluid
7
22
3.27
1.90
2.3
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
6
17
3.61
1.85
1.2
2.5
%
0.3
0.3
—
6
10
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
32
203
1.70
1.85
2.1
2.8
e6/l
0.7
0.9
0.33
22
114
(3013512) EKG study
52
373
1.55
1.84
5.1
3.9
—
—
—
0
0
(4035726)
19
102
1.96
1.84
1.4
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
12
4.25
1.83
1.0
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
43
296
1.59
1.81
9.6
5.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
18
3.41
1.76
1.3
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
6
18
3.41
1.76
1.2
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
102
1185
0.68
1.76
3.8
4.6
mmol/l
4.2
4.5
2.63
93
1081
(3029937) Albumin [Presence] in Urine by Test strip
49
352
1.54
1.72
5.6
3.8
estimate
0.0
0.0
0.00
21
105
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
101
1172
0.69
1.69
3.8
4.5
mmol/l
1.5
1.5
0.51
92
1051
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
20
3.07
1.59
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
57
2.18
1.59
1.4
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
23
139
1.75
1.57
2.0
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
7
27
2.66
1.53
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
44
317
1.51
1.51
1.6
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
16
3.18
1.45
1.8
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
60
2.07
1.41
14.1
8.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
14
75
1.94
1.38
2.6
3.5
%
0.3
0.3
—
6
17
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
17
2.99
1.37
1.0
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
17
2.99
1.37
1.0
1.6
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
74
601
1.39
1.34
5.0
3.4
estimate
0.0
0.0
0.00
22
110
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
135
1214
1.45
1.33
35.6
12.6
mg/l
31.2
26.8
0.95
124
948
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
29
411
0.65
1.32
3.9
4.5
%
21.5
21.8
0.04
17
210
(3034770) Mitochondria Ab [Titer] in Serum
6
24
2.55
1.31
1.0
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
21
131
1.68
1.30
1.4
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
5
18
2.83
1.29
1.2
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
100
1136
0.73
1.26
3.6
4.1
mmol/l
1.1
1.2
2.39
89
1014
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
100
1136
0.73
1.26
4.9
6.3
mmol/mol
38.4
40.7
1.15
89
1047
(36660697) Celiac disease serology panel - Serum
11
57
1.99
1.20
1.0
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
8
39
2.10
1.17
3.8
2.7
mg/l
2.1
1.8
—
8
34
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
16
97
1.71
1.11
3.5
2.7
ng/l
664.7
164.4
1.33
16
88
(3017143) Hepatitis C virus Ab [Presence] in Serum
16
97
1.71
1.11
1.4
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
44
338
1.40
1.09
5.2
3.1
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
7
33
2.17
1.07
1.6
1.4
—
3.5
—
0
5
(3005322) IgE [Units/volume] in Serum or Plasma
11
60
1.89
1.05
1.3
1.1
u/ml
699.8
122.3
0.57
11
54
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
11
60
1.89
1.05
1.0
1.2
iu/ml
195.6
109.9
—
5
19
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
20
131
1.59
1.05
1.6
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
22
2.31
1.04
1.0
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
73
614
1.32
1.00
5.1
3.4
estimate
0.0
0.0
0.00
22
101
(3021601) Nitrite [Presence] in Urine by Test strip
72
606
1.31
0.98
6.1
4.5
estimate
0.0
0.0
0.00
22
107
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
27
2.26
0.94
2.3
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
28
2.18
0.92
1.0
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
19
128
1.54
0.90
1.3
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
8
43
1.90
0.88
1.5
1.9
u/l
39.1
40.6
—
8
37
(3019550) Sodium [Moles/volume] in Serum or Plasma
136
1260
1.32
0.85
38.8
16.1
mmol/l
138.0
139.8
8.65
130
1214
(3023103) Potassium [Moles/volume] in Serum or Plasma
136
1263
1.31
0.81
38.9
16.3
mmol/l
4.0
4.0
0.05
130
1217
(1761868) Lipid panel - Serum or Plasma
30
384
0.74
0.77
2.9
3.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
24
2.11
0.75
1.4
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
34
425
0.75
0.74
4.0
4.1
mg/mmol
29.6
9.3
0.60
22
270
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
38
1.88
0.74
1.3
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
9
58
1.58
0.71
2.1
2.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
118
1086
1.25
0.70
4.9
4.3
mu/l
2.0
2.0
0.05
107
947
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
27
1.88
0.69
1.8
1.1
—
—
—
0
0
(3000492) Spirometry study
5
94
0.52
0.68
1.0
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
56
477
1.25
0.67
5.6
3.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
28
1.81
0.66
1.0
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
18
130
1.43
0.64
1.2
1.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
32
395
0.77
0.64
4.1
3.3
mg/l
3490.7
223.2
0.78
23
263
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
30
1.69
0.62
3.2
2.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
64
1.60
0.60
1.5
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
22
0.00
0.59
0.0
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
68
599
1.22
0.59
3.0
2.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
8
54
1.50
0.58
1.3
1.4
—
60.9
—
0
6
(3022621) pH of Urine by Test strip
13
90
1.48
0.57
4.0
2.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
11
159
0.67
0.57
12.8
7.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
9
62
1.48
0.54
2.0
2.7
—
19.3
—
0
5
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
64
1.43
0.52
2.4
2.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
11
75
1.50
0.52
1.5
1.7
—
—
—
0
0
(3020891) Body temperature
7
48
1.48
0.47
16.4
3.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
139
1331
1.19
0.41
47.2
19.9
e9/l
261.5
240.9
2.33
134
1292
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
15
0.00
0.41
0.0
2.1
—
6.6
—
0
15
(3026361) Erythrocytes [#/volume] in Blood
139
1333
1.19
0.40
47.2
19.9
e12/l
3.9
4.5
21.24
134
1284
(3010813) Leukocytes [#/volume] in Blood
139
1333
1.19
0.40
47.2
19.9
e9/l
7.6
6.8
3.42
134
1288
(3024731) MCV [Entitic volume]
139
1333
1.19
0.40
47.1
19.9
fl
93.7
91.3
4.67
134
1302
(3035941) MCH [Entitic mass]
139
1333
1.19
0.40
47.0
19.8
pg
30.8
30.3
1.83
134
1302
(3000963) Hemoglobin [Mass/volume] in Blood
139
1334
1.18
0.39
47.7
20.0
g/l
118.5
134.2
21.49
134
1301
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
68
1.34
0.38
1.6
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
110
1041
1.15
0.36
29.2
15.2
%
36.2
38.9
2.04
68
699
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
10
73
1.39
0.35
1.6
1.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
47
523
0.86
0.34
3.8
5.5
ug/l
1.8
3.2
1.29
42
450
(3011397) Hemoglobin [Presence] in Urine by Test strip
31
271
1.17
0.29
4.4
3.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
31
274
1.16
0.26
5.9
3.8
kg/l
1.0
1.0
—
6
42
(40768804) Tissue Pathology biopsy report
54
497
1.12
0.26
2.6
2.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
119
1145
1.12
0.25
31.9
13.1
ml/min/173m2
74.7
73.3
0.26
109
920
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
39
1.29
0.23
2.2
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
42
1.20
0.21
3.6
1.6
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
1.2
—
0
5
(3025130) Human papilloma virus identified in Specimen
0
12
0.00
0.21
0.0
2.5
—
—
—
0
0
(4146454)
0
13
0.00
0.21
0.0
3.0
—
—
—
0
0
(3002256) Pathology report gross observation
14
162
0.85
0.17
1.6
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
115
1182
0.93
0.16
4.0
4.9
mmol/l
6.0
6.1
0.14
102
1055
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
19
169
1.14
0.15
1.2
1.2
u/ml
49.1
12.4
—
6
68
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
11
93
1.19
0.15
1.7
3.5
ml/min/173m2
55.0
57.8
—
5
41
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
20
180
1.13
0.14
1.4
1.2
iu/ml
40.6
44.3
—
7
67
(40761511) CBC panel - Blood by Automated count
129
1268
1.06
0.10
36.5
12.5
—
—
—
0
0
(3044889) 12 lead EKG panel
88
859
1.05
0.08
4.9
4.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
63
0.79
0.08
1.0
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
144
0.97
0.00
1.5
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
10
99
1.01
0.00
1.5
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
10
101
0.99
0.00
5.5
3.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
16
162
0.99
0.00
3.5
4.8
%
40.6
31.8
1.83
11
107
(44806420)
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
6
0.00
0.00
0.0
3.0
—
71.8
—
0
6
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
9
0.00
0.00
0.0
2.3
—
11.0
—
0
9
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.4
—
8.9
—
0
8
(3035320) C reactive protein [Mass/volume] in Body fluid
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
58
0.86
0.00
1.2
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
4.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
9.6
—
0
7
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
64
0.94
0.00
1.2
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
61
0.98
0.00
6.2
3.2
—
—
—
0
0
(4010399)
7
70
1.00
0.00
1.4
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_CACHEXIA – Cachexia
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).